Haleon PLC Sponsored ADR (NYSE:HLN) Receives Average Rating of “Moderate Buy” from Brokerages

Haleon PLC Sponsored ADR (NYSE:HLN) has been assigned an average recommendation of “Moderate Buy” from the nine ratings firms that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, three have assigned a hold rating, three have issued a buy rating and two have given a strong buy rating to the company.

Several research firms have recently commented on HLN. Wall Street Zen raised shares of Haleon from a “hold” rating to a “buy” rating in a research note on Saturday, March 21st. Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Haleon in a research note on Thursday, April 30th. Rothschild & Co Redburn cut shares of Haleon from a “strong-buy” rating to a “hold” rating in a research note on Tuesday. Finally, Argus upgraded shares of Haleon to a “strong-buy” rating in a research report on Tuesday, March 17th.

Institutional Investors Weigh In On Haleon

Several institutional investors have recently modified their holdings of HLN. Norges Bank acquired a new stake in shares of Haleon during the 4th quarter worth approximately $163,529,000. Natixis Advisors LLC grew its position in shares of Haleon by 429.8% during the 4th quarter. Natixis Advisors LLC now owns 10,003,941 shares of the company’s stock worth $101,140,000 after buying an additional 8,115,633 shares during the period. Arrowstreet Capital Limited Partnership grew its position in shares of Haleon by 4,315.4% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 8,027,189 shares of the company’s stock worth $81,155,000 after buying an additional 7,845,391 shares during the period. Bank of Montreal Can grew its position in shares of Haleon by 454.1% during the 4th quarter. Bank of Montreal Can now owns 8,500,496 shares of the company’s stock worth $85,940,000 after buying an additional 6,966,416 shares during the period. Finally, Bank of America Corp DE grew its position in shares of Haleon by 116.7% during the 2nd quarter. Bank of America Corp DE now owns 12,384,135 shares of the company’s stock worth $128,423,000 after buying an additional 6,669,923 shares during the period. Institutional investors and hedge funds own 6.67% of the company’s stock.

Haleon Price Performance

HLN opened at $8.97 on Friday. Haleon has a one year low of $8.65 and a one year high of $11.28. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.92 and a quick ratio of 0.71. The company’s 50 day simple moving average is $9.25 and its 200-day simple moving average is $9.88. The stock has a market capitalization of $39.66 billion, a P/E ratio of 22.99, a price-to-earnings-growth ratio of 2.06 and a beta of 0.13.

Haleon (NYSE:HLN) last released its quarterly earnings results on Saturday, February 14th. The company reported $6.32 EPS for the quarter. The company had revenue of $3.65 billion for the quarter. Sell-side analysts anticipate that Haleon will post 0.55 earnings per share for the current fiscal year.

About Haleon

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.